Pharma major Lupin Limited

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Tacrolimus Capsules USP

Mumbai, November 12, 2020: Pharma major Lupin Limited (Lupin) in alliance with Concord Biotech Limited (Concord) announced today that it…

4 years ago

Lupin Launches Lapatinib Tablets

Mumbai, September 30, 2020: Pharma major Lupin Limited (Lupin) announced today the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance…

4 years ago

Lupin Signs Exclusive Distribution Pact with ForDoz Pharma for 2 Complex Injectable Assets Under Development

Mumbai, Baltimore, August 06, 2020: Pharma major Lupin Limited (Lupin) announced today that its U.S. based wholly-owned subsidiary Lupin Pharmaceuticals…

4 years ago

Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19

Mumbai, August 05, 2020: Pharma major Lupin Limited (Lupin) today announced the launch of its Favipiravir in India under the…

4 years ago

Lupin Receives Tentative Approval for Empagliflozin Tablets

Mumbai, August 04, 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin Tablets, 10…

4 years ago

Lupin Receives Tentative Approval for Empagliflozin and Linagliptin Tablets

Mumbai, July 23 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin and…

4 years ago